Important Notice
If you are HIV-positive, RAuro-Emtricitabine-Tenofovir should only be combined with other antiretroviral agents. For more information, please consult your healthcare professional. For Pre-Exposure Prophylaxis, PrAuro-Emtricitabine-lenotovir is indicated in combination with safer sex practices for PrEP to reduce the risk of sexually acquired HIV-1 infection in adults at high risk. This material was developed by Auro Pharma, as part of the risk minimization plan for PrAuro-Emtricitabine-Tenofovir. This material is not intended for promotional use.
Follow the links below to get more information about PrAuro-Emtricitabine-Tenofovir:
Additional Information:
The information above does not constitute medical advice. Consult your doctor or pharmacist for more information about the product or possible side effects.
You can report any suspected adverse reactions associated with the
use of health products (becoming HIV-1 positive while on Auro-Emtricitabine-tenofovir for PrEP is considered an adverse event) to the Canadian Vigilance Program at 1-866-234-2345 or online at www.healthcanada.gc.ca/medeffect
Follow Us:
Customer Support
Phone: +1-905-856-8063
Email: cs@auropharma.ca
Follow Us:
Medical information
Phone: +1-855-648-6681
Email: pvteam@auropharma.ca
